PharVision Advisers’s Diginex Ltd DGNX Stock Holding History

PharVision Advisers’s Portfolio DGNX Stock Details DGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,274	Closed	-$262K	–	1056
2025 Q3	$262K	Buy	+2,274	New	+$152K	0.15%	305

Other funds holding DGNX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's DGNX Position: Q4 2025 in Review

PharVision Advisers sold out of Diginex Ltd (DGNX) in Q4 2025, closing a stake of 2,274 shares — an estimated $262K sold.

PharVision Advisers first reported a position in DGNX in Q3 2025 and held it in 1 quarter. The position peaked at $262K in Q3 2025. 40 funds tracked by Wall St. Rank hold DGNX as of Q4 2025.

PharVision Advisers reported no remaining Diginex Ltd position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 2,274 Diginex Ltd shares in Q4 2025, an estimated $262K.
PharVision Advisers first reported a position in Diginex Ltd in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Diginex Ltd position peaked at $262K in Q3 2025.
40 funds tracked by Wall St. Rank held Diginex Ltd as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.